Table 1.
Main characteristics of the main study sample and the secondary study sample.
Table 2.
Mean plasma amyloid-β levels by quartiles of distribution of IgM or IgG antibodies to herpes simplex virus in the main study sample (n = 1222).
Table 3.
Mean plasma amyloid-β levels by quartiles of distribution of IgM or IgG antibodies to herpes simplex virus in the secondary study sample (n = 754).
Table 4.
Associations between plasma amyloid-ß levels and IgM antibodies to herpes simplex virus in the main study sample (n = 1222).
Table 5.
Associations between plasma amyloid-β levels and IgM antibodies to herpes simplex virus in the secondary study sample with CR1- and CLU-linked SNPs available data (n = 754).
Figure 1.
Design of the case-control study, definition of the main study sample and of the secondary study sample.
Abbreviations: HSV, herpes simplex virus; Aβ, Amyloid-beta; 3C, Three-City Study.